DOP2001000211A - Uso de cepas de parapoxvirus ovis para la fabricación de medicamentos antivirales y medicamentos contra el cancer - Google Patents
Uso de cepas de parapoxvirus ovis para la fabricación de medicamentos antivirales y medicamentos contra el cancerInfo
- Publication number
- DOP2001000211A DOP2001000211A DO2001000211A DO2001000211A DOP2001000211A DO P2001000211 A DOP2001000211 A DO P2001000211A DO 2001000211 A DO2001000211 A DO 2001000211A DO 2001000211 A DO2001000211 A DO 2001000211A DO P2001000211 A DOP2001000211 A DO P2001000211A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- drugs
- manufacture
- parapoxvirus ovis
- straps
- against cancer
- Prior art date
Links
- 241000283898 Ovis Species 0.000 title abstract 4
- 241000700639 Parapoxvirus Species 0.000 title abstract 4
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000003443 antiviral agent Substances 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 230000002458 infectious effect Effects 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10033582 | 2000-07-11 | ||
| DE10122451A DE10122451A1 (de) | 2000-07-11 | 2001-05-09 | Verwendung von Stämmen des Parapoxvirus ovis zur Herstellung von antiviralen Arzneimitteln und Arzneimitteln gegen Krebs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2001000211A true DOP2001000211A (es) | 2002-12-15 |
Family
ID=7648486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2001000211A DOP2001000211A (es) | 2000-07-11 | 2001-07-11 | Uso de cepas de parapoxvirus ovis para la fabricación de medicamentos antivirales y medicamentos contra el cancer |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JP2012121902A (pt) |
| KR (1) | KR100805996B1 (pt) |
| BR (1) | BRPI0112407B8 (pt) |
| DE (1) | DE10122451A1 (pt) |
| DO (1) | DOP2001000211A (pt) |
| EC (1) | ECSP034419A (pt) |
| GT (1) | GT200100136A (pt) |
| HN (1) | HN2001000154A (pt) |
| PE (1) | PE20020187A1 (pt) |
| SV (1) | SV2002000528A (pt) |
| TW (1) | TWI304341B (pt) |
| ZA (1) | ZA200300274B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023083943A1 (en) * | 2021-11-10 | 2023-05-19 | Aicuris Gmbh & Co. Kg | Parapoxvirus for preparing for and treatment of respiratory virus infections in combination with antivirals |
| WO2023083950A1 (en) * | 2021-11-10 | 2023-05-19 | Aicuris Gmbh & Co. Kg | Parapoxvirus for preparing for and treatment of respiratory virus infections in combination with immunomodulators |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2714665A1 (de) * | 1977-04-01 | 1978-10-05 | Mayr Anton | Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung |
| DE4405841C1 (de) * | 1994-02-23 | 1995-01-05 | Mayr Anton Prof Dr Med Vet Dr | Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| EP0904393A4 (en) * | 1996-03-29 | 1999-09-08 | Univ Otago | PARAPOXVIRUS VECTORS |
| AU775956B2 (en) * | 1998-11-02 | 2004-08-19 | Otago Innovation Limited | Vascular endothelial growth factor-like protein from ORF virus NZ2 binds and activates mammalian VEGF receptor-2 |
-
2001
- 2001-05-09 DE DE10122451A patent/DE10122451A1/de not_active Withdrawn
- 2001-07-10 PE PE2001000682A patent/PE20020187A1/es not_active Application Discontinuation
- 2001-07-10 HN HN2001000154A patent/HN2001000154A/es unknown
- 2001-07-11 BR BRPI0112407-2 patent/BRPI0112407B8/pt not_active IP Right Cessation
- 2001-07-11 KR KR1020037000308A patent/KR100805996B1/ko not_active Expired - Lifetime
- 2001-07-11 DO DO2001000211A patent/DOP2001000211A/es unknown
- 2001-07-11 SV SV2001000528A patent/SV2002000528A/es not_active Application Discontinuation
- 2001-07-11 GT GT200100136A patent/GT200100136A/es unknown
- 2001-07-11 TW TW090116912A patent/TWI304341B/zh not_active IP Right Cessation
-
2003
- 2003-01-10 EC EC2003004419A patent/ECSP034419A/es unknown
- 2003-01-10 ZA ZA200300274A patent/ZA200300274B/en unknown
-
2012
- 2012-02-03 JP JP2012021508A patent/JP2012121902A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030016387A (ko) | 2003-02-26 |
| HN2001000154A (es) | 2001-09-21 |
| ECSP034419A (es) | 2003-03-10 |
| ZA200300274B (en) | 2004-01-22 |
| KR100805996B1 (ko) | 2008-02-26 |
| TWI304341B (en) | 2008-12-21 |
| BRPI0112407B8 (pt) | 2021-05-25 |
| PE20020187A1 (es) | 2002-05-19 |
| BR0112407A (pt) | 2003-07-22 |
| JP2012121902A (ja) | 2012-06-28 |
| DE10122451A1 (de) | 2002-04-04 |
| GT200100136A (es) | 2002-07-03 |
| BRPI0112407B1 (pt) | 2019-02-12 |
| SV2002000528A (es) | 2002-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26832A1 (es) | Uso de cepas de parapoxvirus ovis para la fabricacion de medicamentos antivirales y medicamentos contra el cancer | |
| UY28294A1 (es) | Dihidroquinazolinas sustituidas | |
| WO2018190719A3 (en) | Anti-sirp alpha antibodies | |
| UY27186A1 (es) | Formulación farmacéutica | |
| TNSN07150A1 (en) | Semi-soft c-class immunostimulatory oligonucleotides | |
| BRPI0416205A (pt) | uso de antibióticos como adjuvantes de vacina | |
| WO2015058772A3 (en) | Novel hcv culture systems and direct-acting antiviral sensitivity | |
| UY28313A1 (es) | Nonadepsipeptidos acilados | |
| AR053775A1 (es) | Nonadepsipeptidos acilados ii | |
| DOP2001000211A (es) | Uso de cepas de parapoxvirus ovis para la fabricación de medicamentos antivirales y medicamentos contra el cancer | |
| PA8590801A1 (es) | Derivados de nucleosido antivirales | |
| BR112021006388A2 (pt) | composto, composição farmacêutica, uso de um composto, e, método para tratamento de uma infecção viral em um mamífero | |
| PL1765370T3 (pl) | Parapoksywirusy w kombinacji z innymi czynnikami przeciwwirusowymi do leczenia HIV/AIDS | |
| CO2023005389A2 (es) | Vacuna terapéutica que comprende un antígeno específico de una enfermedad que no afecta al sistema nervioso central y nanopartículas y su uso | |
| HN2000000078A (es) | Amidas sustituidas del acido fenilciclohexanocarboxilico y su uso como inhibidores de la incorporacion de adenosina | |
| ATE406888T1 (de) | Cyanoacrylat-zusammensetzungen für die therapeutische behandlungvon wunden, die eine revision erfordern | |
| WO2002067951A3 (de) | Verwendung von 5-substituierten nukleosiden und/oder deren prodrugs zur resistenzfreien therapie von infektionskrankheiten | |
| BR0008269A (pt) | Uso de uma preparação de m. vaccae, e, método para tratamento de infecção viral crÈnica, excluindo infecção por hiv | |
| DK1150981T3 (da) | Terapeutisk necleosidforbindelse | |
| Okamoto | The 44th Scientific Meeting: Perspectives of Internal Medicine: Virology for Physician∼ Recent Advance in Viral Infection and Treatment∼: 3. Common Viral Infectious Diseases; Viral Hepatitis: 3) Hepatitis A and E | |
| AR043099A1 (es) | Oligonucleotidos inmunoestimulantes y sus usos | |
| UY28110A1 (es) | Derivados de nucleosido antivirales | |
| ES2154604B1 (es) | Medicacion de uso topico aplicable para el tratamiento de enfermedades producidas por virus, especialmente el herpes simplex de los tipos h sv1 y hsv2 | |
| MX2008016111A (es) | Uso del ácido acetilsalicílico en terapia antiviral. |